| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 78 |
| 1 | METHOTREXATE SODIUM | 75 |
| 2 | ETOPOSIDE | 71 |
| 3 | PREDNISONE | 69 |
| 4 | CYTARABINE | 67 |
| 5 | METHOTREXATE | 66 |
| 6 | PEGASPARGASE | 64 |
| 7 | CYCLOPHOSPHAMIDE | 62 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 62 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 16 | 0.0097 |
| 1 | PEGASPARGASE | 64 | 0.0052 |
| 2 | MERCAPTOPURINE | 62 | 0.0036 |
| 3 | CALCIUM FOLINATE | 12 | 0.0025 |
| 4 | HYDROCORTISONE SODIUM SUCCINATE | 10 | 0.0025 |
| 5 | FILGRASTIM | 59 | 0.0016 |
| 6 | VINCRISTINE SULFATE | 44 | 0.0015 |
| 7 | TREOSULFAN | 4 | 0.0014 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 11 | 0.0014 |
| 9 | ARSENIC TRIOXIDE | 3 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 139 |
| 1 | Alkylating Drug [EPC] | 72 |
| 2 | Topoisomerase Inhibitor [EPC] | 71 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 69 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 66 |
| 5 | Asparagine-specific Enzyme [EPC] | 64 |
| 6 | Leukocyte Growth Factor [EPC] | 59 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 8 | Azole Antifungal [EPC] | 22 |
| 9 | Calcium Channel Blocker [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 64 | 0.0047 |
| 1 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 2 | Topoisomerase Inhibitor [EPC] | 71 | 0.0009 |
| 3 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 5 | Polyene Antifungal [EPC] | 17 | 0.0004 |
| 6 | Leukocyte Growth Factor [EPC] | 59 | 0.0004 |
| 7 | Recombinant Human Deoxyribonuclease 1 [EPC] | 8 | 0.0004 |
| 8 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Cephalosporin Antibacterial [EPC] | 3 | 0.0003 |